Safety and efficacy of LY2951742, a monoclonal antibody to calcitonin gene-related peptide, for the prevention of migraine: a phase 2, randomised, double-blind, placebo-controlled study. (Q51703728)
Jump to navigation
Jump to search
scientific article published on 10 August 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Safety and efficacy of LY2951742, a monoclonal antibody to calcitonin gene-related peptide, for the prevention of migraine: a phase 2, randomised, double-blind, placebo-controlled study. |
scientific article published on 10 August 2014 |
Statements
Safety and efficacy of LY2951742, a monoclonal antibody to calcitonin gene-related peptide, for the prevention of migraine: a phase 2, randomised, double-blind, placebo-controlled study. (English)
1 reference
Peter J Goadsby
1 reference
David W Dodick
1 reference
Egilius L H Spierings
1 reference
Joel C Scherer
1 reference
Steven P Sweeney
1 reference
David S Grayzel
1 reference
10 August 2014
1 reference
13
1 reference
9
1 reference
885-892
1 reference